Back to Results
First PageMeta Content
Food and Drug Administration / Clinical research / Acute leukemia / Acute myeloid leukemia / Clinical trial / Chronic myelogenous leukemia / Minimal residual disease / Vaccination / Regulatory requirement / Medicine / Health / Myeloid leukemia


MAIN TRIAL CONTACT Chief Investigator and Laboratory Lead: Professor Christian Ottensmeier Somers Cancer Research Building Cancer Sciences Division Southampton General Hospital
Add to Reading List

Document Date: 2013-09-26 21:43:02

Open Document

File Size: 1,00 MB

Share Result on Facebook

City

Southampton / San Diego / /

Company

TRIAL MANAGEMENT / Abbreviations ABPI AE / WIN Trial Inovio Biomedical Corporation / TRIAL MANAGEMENT GROUP / Adverse Reaction Aspartate / /

/

Event

Judicial Event / Product Issues / FDA Phase / Product Recall / Force Majeure / /

Facility

University of Southampton Clinical Trials Unit MP131 / m.r.bowers@soton.ac.uk University of Southampton Clinical Trials Unit Southampton General Hospital / Laboratory Cancer Sciences Division Tremona Road / University of Southampton Clinical Trials Unit Southampton General Hospital / j.goldman@imperial.ac.uk Bristol Institute / Hospital Barrack Road / Joint R&D Office Duthie Building / University of Southampton Clinical Trials Unit / NBS Bristol Institute / Southampton Clinical Trials / /

/

MedicalCondition

chronic phase Complete Molecular response Cytomegalovirus Complete Response Case Report Form Computerised tomography Clinical Trial Authorisation Common Terminology Criteria / tetanus / IMMEDIATE HYPERSENSITIVITY / Leukaemia / leukaemia Chronic myeloid leukaemia / Cancer / SARS / Chronic / PAIN / SLE / /

MedicalTreatment

PAIN MANAGEMENT / /

Organization

fs@soton.ac.uk Professor John Goldman Department of Haematology Imperial College/Hammersmith Hospital Du Cane Road / World Health Organization / d.marin@imperial.ac.uk Dr Paul Kerr Department of Haematology Royal Devon and Exeter Hospital Barrack Road / Food and Drug Administration / DATA MONITORING AND ETHICS COMMITTEE / University of Southampton Clinical Trials Unit White Blood Cells World Health Organisation Wilms Tumour / IM IMP ISF ISS MDS MHC MHRA MRD WIN Trial Association / Dr Katy Rezvani Department of Haematology Imperial College/Hammersmith Hospital Du Cane Road London / matthew.jenner@suht.swest.nhs.uk Dr David Marin-Costa Department of Haematology Imperial College/Hammersmith Hospital Du / University of Southampton Clinical Trials Unit MP131 / k.rezvani@imperial.ac.uk Dr Matthew Jenner Department of Haematology Southampton General Hospital Tremona Road / NBS Bristol Institute / m.r.bowers@soton.ac.uk University / Clinical Investigators Dr Katy Rezvani Department of Haematology Imperial College/Hammersmith Hospital Du Cane Road / Southampton Clinical Trials Unit / Dr Anthony Williams Cancer Sciences Division / FDA / NHS / University of Southampton / j.goldman@imperial.ac.uk Bristol Institute for Transfusion Sciences / ETHICS COMMITTEE / /

Person

Christian Ottensmeier Somers / Ground Floor / Freda K Stevenson Tenovus / Megan Bowers (Statistician) / Matthew Jenner / Debbie Hamid / Paul Lloyd-Evans / Katy Rezvani / Paul Kerr / John Goldman / Scott Regan / David Marin-Costa / /

/

Position

Investigator / Statistician / Human Leukocyte Antigen A2 Investigator / TRIAL CONTACT Chief Investigator / MP / Southampton General / Messenger / immune alert signal Principal Investigator Research / Director of Research and Development / Professor / Coordinator / Trial Coordinator / Trial Manager / /

Product

SELECTION AND / CONCURRENT MEDICATION / INCLUSION CRITERIA EXCLUSION CRITERIA REGISTRATION PROCEDURE / STUDY / ASSESSMENT / /

ProvinceOrState

California / /

Technology

tomography / ANTIBODIES / 2012 Protocol Information This protocol / 57 29 29 29 29 30 Protocol / Gene Therapy / ELECTROPORATION / DOM / 57 Protocol / 57 39 40 40 Protocol / /

URL

www.uhs.nhs.uk / www.ctu.soton.ac.uk / /

SocialTag